chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Rash started on rt. thigh (same leg as vaccination site) within 2-3 hours, it had spread over entire body, excluding head. Rash started to diminish after 48 hours, but on 9/11/11 a few fluid-filled vesicles were noted on chest, back and eyebrow.  On 9/12 a few more vesicles appeared on wrist, foot and hairline.
About three weeks after vaccination: Bulging fontanelle, change in cry, low fever (100.4) possibly associated with cold not vaccine reaction. Spinal Tap performed at Hospital to rule out bacterial, viral, or fungal infection of central nervous system; no infection found after blood, urine, and spinal fluid samples tested. The multiple physicians told us it was "just her normal range of fluid".
Fatigue, headache, body aches, GI distress on 1st day after immunization. On 7/12/03 pt had fever and body aches with headaches. Extremity weakness. Resolved after 14 days.
It was a sudden onset of diarrhea, vomiting, and vertigo (bad).  I have no idea if the shot caused it, but it lasted about an hour, and that was it. I called Medical Ctr to ask if the flu shot could have caused it, and they said it might have been possible, but they had no way to know. When I am sick from codeine, I feel much the same way, so I figured it might have been a reaction to the flu shot, but I don't know. Thought I'd report it.
Injection was given sub-q in lower portion of upper arm instead of IM in deltoid.  Experienced pain, redness, heat and swelling at site for the past 3 days. These symptoms are still ongoing.
States after last injection had severe pain in left shoulder starting about 3 days after injection on 11/17/05. Pain lasted about 3 weeks went to health science center and was seen by MD there. States was told that she had muscle trauma from the injection. States MD prescribed Tylenol 3 for pain. Denies any pain or problems currently with shoulder.
Chills; Fever; Aches and pains/throbbing of a headache; Aches and pains/throbbing of a headache; This is a spontaneous report from a contactable consumer. A 70-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) lot number EL9261, via an unspecified route of administration on 24Jan2021 at SINGLE DOSE for covid-19 immunisation. Medical history included COVID-19 flu six months ago. There were no concomitant medications. The patient experienced chills on 25Jan2021 01:00 with outcome of recovering, fever on 25Jan2021 01:00 with outcome of recovering, aches and pains/throbbing of a headache on 25Jan2021 01:00 with outcome of recovering. Her symptoms all started about 1AM, she was woken up to them. Chills: they are better, she has an ice pack on her head for the throbbing of a headache. The action taken was not applicable. She wanted to take a Tylenol. It will probably go away tomorrow she was hoping to get some relief in the mean time.
Patient states her symptoms started on Saturday morning after Covid booster and include left arm pain that radiated to shoulder and neck with "tightness" . Additionally, she experienced body aches, fatigue, chills with hot flashes, and nausea without vomiting.
Developed  Tinea Versicolor on right side of Neck.  Treated with topical cream and oral medication.  No further recurrence.
Fast heartbeat (continued until at least 1am 9/27 and slowed at some point before 7am when I awakened. extreme fatigue ( started 3-4pm 9/26 went back to sleep after 7am and awaken again 10:30a still tired)
Initial unsolicited case received from a consumer (patient daughter) on 19 Oct 2016. This case involves a female patient (age not reported) who was vaccinated with a dose of FLU VACCINE (Batch number, expiry date, route, dose and site of administration was not reported) on an unknown date ten years ago. The patient illness at the time of vaccination, pre-existing physician diagnosed allergies, birth defects, medical conditions was reported as not provided and any other vaccinations within four weeks of vaccinations was reported as none. The patient concomitant medications were not reported. On an unknown date, after vaccination the patient experienced with Guillain Barre Syndrome. On an unknown date the patient was hospitalized which resulted in prolonged hospitalization and she spent time in nursing home. The patient corrective treatment was not reported. The patient lab tests were not reported. (Reported as unable to provide information). The outcome of the event was reported as recovered on an unknown date. It was reported that doctor told the patient that event was directly related to a vaccine. List of documents held by sender: none. Sender's Comments: Guillain Barre Syndrome is unlisted with INFLUENZA VACCINE (Unknown manufacturer). This is poorly documented case. However, investigation results ruling out a concurrent condition and other etiologies would be helpful to further assess this case.
As reported to us per pt. Developed high itching at 5pm, "collapsed" to ER via ambulance-given IV Benadryl, home 9 hrs later. 5hrs post home back to ER-epi.+IV Benadryl-admitted for 1 day, d/c home. The hospital record received on 3/5/04 states collapsed, urticaria and allergic reaction.
This spontaneous report as received from a pharmacist refers to a newborn (female) patient of unknown age. On 25-OCT-2012 13:58, the patient was vaccinated with RECOMBIVAX HB that had been exposed to temperatures below 32F for 6 hours. During that 6 hour time period, the vaccine was exposed to 28.8F for 1.5 hours. Administration route was not reported. Two lot# were involved and the lot# were reported as: 0294AE, expiry date on 06-SEP-2014; and 0385AE, expiry date on 08-NOV-2014. It was unspecified which lot# the patient was administered. The outcome of event was unknown. It was unspecified if the patient sought medical attention. This is one of several reports received from the same source. Additional information has been requested.
Tested positive for COVID-19; This spontaneous case was reported by a pharmacist and describes the occurrence of SARS-COV-2 TEST POSITIVE in a 36-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014M20A and 032L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Dec-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced SARS-COV-2 TEST POSITIVE (Tested positive for COVID-. At the time of the report, SARS-COV-2 TEST POSITIVE outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available) on 28-Dec-2021, SARS-CoV-2 test positive.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment information was reported.  Company comment: This is a spontaneous case concerning a 36-year-old, male patient with no reported medical history, who experienced the unexpected, non serious, AESI event of SARS-CoV-2 test positive. The patient received first and second dose of mRNA-1273 vaccine with appropriate dosage interval of 28 days. The event SARS-CoV-2 test positive occurred 305 days after the second dose of mRNA-1273 vaccine administration. No reported treatment medication. The outcome of the event was unknown. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.   This case was linked to MOD-2021-433545 (Patient Link).
My son was given a combo vaccine of DTap and Polio on the left arm on Wednesday May 12, 2021. The day after he developed a nasty big red rash around injection site and a big lump where the injection was put. He wouldn't move his arm for the first 3 days, he complained of a lot of pain. I took him to urgent care and the Dr. said it was a localized reaction. This is day 5 and his injection site still has a big lump and is still red. Dr. prescribed an antibiotic cream.
not feeling well; Arm is very sore; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (not feeling well) and PAIN IN EXTREMITY (Arm is very sore) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Anemia and Bradycardia.    On 22-Jun-2021 at 11:15 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jun-2021, the patient experienced MALAISE (not feeling well) and PAIN IN EXTREMITY (Arm is very sore). At the time of the report, MALAISE (not feeling well) and PAIN IN EXTREMITY (Arm is very sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not provided by reporter. Treatment information was not provided by reporter.   Most recent FOLLOW-UP information incorporated above includes: On 22-Jun-2021: Consent for follow-up updated.
widespread chickenpox w/few infected tiny vesicles, large erythema, widespread all over body;vaccinated against varicella 12FEB98 given Keflex d/t infect just diagnosed;
Stomach pain followed by watery diarrhea at 2:00 PM Vomiting and diarrhea at 3:00 AM, No other symptoms. No fever, felt fine in between occurances.
Father, reports patient seemed emotionless, lethargic for about 8 days. She seemed to stop making developmental progress for about 3 weeks and seemed to make less sounds. She also had some diffuse red spots that are now resolving. She has now been back to her baseline, seems alert and dad says she seems to be making good developmental progress. Her exam today was unremarkable with normal tone and alertness. She has a single faint red papule on her left lower leg.
2/14/21 experienced soreness at site of injection. 2/15/21 & 2/16/21 experienced flu-like symptoms (fever, extreme fatigue, muscle aches).  2/17/21 severe disorientation, feelings of dementia, nausea, difficulty walking, affecting L side, feelings of panic & agoraphobia, extreme fatigue, unable to complete any meaningful tasks.  2/18/21, 2/19,2/20,2/22 - continuation of symptoms on 2/17/21. 2/22/21 symptoms lessened but continued fatigue followed by 2/17/21 symptoms. These symptoms have continued  intermittently until present day. (3/1/21)
Muscle ache, golf size bump sore to touch, itchy and warm to touch, headache that started  01-13 / current.  treatments : Tylenol as needed and putting ice on arm to calm the itchy.
Myalgia, Arthralgia, Fever, Diarrhea, Nausea Vomiting, fatigue Narrative:
has a bump; redness all around like a bull's eye; pain in my arm/moderate pain; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (has a bump), VACCINATION SITE ERYTHEMA (redness all around like a bull's eye) and VACCINATION SITE PAIN (pain in my arm/moderate pain) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032F21A, 031B21A. and 044A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-Oct-2021, the patient experienced VACCINATION SITE MASS (has a bump), VACCINATION SITE ERYTHEMA (redness all around like a bull's eye) and VACCINATION SITE PAIN (pain in my arm/moderate pain). At the time of the report, VACCINATION SITE MASS (has a bump), VACCINATION SITE ERYTHEMA (redness all around like a bull's eye) and VACCINATION SITE PAIN (pain in my arm/moderate pain) outcome was unknown.            no concomitant and treatment medications are provided by the reporter. Vaccination facility address for dose 1 and 2 is given as Airport, for 3rd dose is Pharmacy/Drug Store.
Whole body red, itchy. Treated with Prednisone and steroid cream (patient does not remember name). Rash has diminished and is being treated again with Prednisone and more cream.
pt recvd vax; high fever, n, flu like sxs; titer done = 1:900; bitten by cat;
the pt came in to the clinic for OV and provider ordered Pfizer booster Bivalent. when pt asked if she had covid card pt stated NO and that vaccine  info should in her chart. based on info in pt's chart she was due to receive bivalent booster. pt was directed to nurse, the nurse again verified covid pre screening questions and asked for covid vaccine card to verify dates in chart. pt stated I do not have it and info should be in my chart. nurse continue with administration of Pfizer covid bivalent booster as per chart she was due.. during post vaccine waiting period pt found covid card in her purse. after nurse reviewed covid vaccine card. pt had received covid vaccine on 12/14/2022 at pharmacy that was not documented in her chart. nurse contacted pharmacy to verify if it was a covid bivalent booster that she had received and confirmed that she had already received a covid bivalent booster and now had received an additional COVID bivalent booster. pt and provider both informed. pt did not have any reaction reported for 15 min observation.
Nurse gave patient ProQuad instead of MMR. The patient is an adult and had no Varicella nor Rubella immunity.  Patient was monitored after vaccine. Patient was informed by the nurse that she received both MMR and Varicella in one vaccine.
Received vaccine at 0730. At 200 H/A started, then nausea/vomiting, fever/chills, myalgia, fatigue, tingly/prickly skin. Multiple episodes of emesis overnight. Temp 38 degrees at 0830 1/15. Sx gradually decreased around 1400 on 1/15.
Patient got the vaccine and was directed to the waiting area after the vaccine. He was sitting in his father's arms and fainted. The family was asked to stay around for 30 minutes after that and 5 minutes later the child threw up.
At 1400 patient received his first shot of Moderna. At 1402 patient complained of dizziness and  lightheaded. Noted patient to be weak and unable to hold his body, leaning for forward. BP sitting at 1404 80/60, HR 68, 02 sat 98% on RA. Patient was placed on Trendelenburg position and BP at 1407 120/60, HR 78, 02 sat 99% on RA and patient was able to verbalized his name, age, today?s date, and location. At 1412  BP lying position 120/70, HR 91, 02 sat 99% on RA and patient at this time stated feeling good also stated usually has the same reaction each time he gets a shot. At 1416 patient was put back in sitting position with BP 110/70, HR 89. At  1418 standing BP 140/68, HR 88, 02 sat 98% on RA. Patient stated father is in the car outside to drive him home. No further treatment  needed. Total treatment time was 18min. Patient left at 1420.
Client's mother reported he had a seizure in car about five minutes after his vaccination. He was examined by private physician who does not believe the child had a seizure, but likely an anxiety rxn.
This spontaneous report received from a consumer concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received COVID-19 vaccine AD26.COV2.S (suspension for injection, intramuscular, batch number: Unknown, and batch number: UNKNOWN expiry: UNKNOWN) .5 ml, start therapy date was not reported for prophylactic vaccination. No concomitant medications were reported. On an unspecified date, the subject experienced fainted after getting vaccine, and flu like symptoms. The action taken with COVID-19 vaccine AD26.COV2.S was not applicable. The outcome of the flu like symptoms and fainted after getting vaccine was not reported. The reporter considered the causality between JNJ-78436735, and faint and flu like symptoms as possible. Company causality between JNJ-78436735, and faint and flu like symptoms was possible. The batch number was not reported and has been requested. This report was serious (Other Medically Important Condition). Additional information was received from consumer on 12-Mar-2021 following information was updated and incorporated into case narrative: Patient demographic details (patient initials and sex) and other identification numbers was added.
This case was reported by a physician to a sales representative and described the occurrence of an injection site reaction in a child who received diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed (Infanrix). The physician reported that five pt's developed an injection site reaction following the admin of Infanrix, however, pt identifiers were not provided. On an unspecified date, the pt received the fifth dose of Infanrix (lot DTPA 632A2) in the arm. At an unspecified time following the admin of Infanrix, the pt experienced an injection site reaction characterized by swelling and redness. The pt was seen at a physician's office. The outcome of the events is unk.
received an expired dose of the Moderna vaccine  from  21Sep2021 to 22Oct2021; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (received an expired dose of the Moderna vaccine  from  21Sep2021 to 22Oct2021) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027B21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (received an expired dose of the Moderna vaccine  from  21Sep2021 to 22Oct2021). At the time of the report, EXPIRED PRODUCT ADMINISTERED (received an expired dose of the Moderna vaccine  from  21Sep2021 to 22Oct2021) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not provided.  Treatment information was not provided.  Maximum time in refrigerator is 24 hours before administration.   The patient received an expired dose of the Moderna vaccine from 21Sep2021 to 22Oct2021.  The vial did not undergo any temperature excursions.
she didn't feel good the last time she had the 1st; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 27Aug2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MALAISE (non-serious) with onset 2021, outcome "unknown", described as "she didn't feel good the last time she had the 1st".  Additional Information: Caller wants to know if she can take the 2nd dose on Monday (20Sep2021) wherein she was scheduled on Friday (17Sep2021). Got the first dose last 27Aug2021. She said she was attending a wedding event. She also said she didn't feel good the last time she had the 1st dose.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
developed extremely swollen lymph nodes in the neck, throat, armpits, back which looks like a christmas tree pattern and the left side of his face from his chin to nose is numb and has not gone away; developed extremely swollen lymph nodes in the neck, throat, armpits, back which looks like a christmas tree pattern and the left side of his face from his chin to nose is numb and has not gone away; This is a spontaneous report from contactable consumer (reported himself). A male patient of 39 (units unspecified) age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, lot number: unknown), via an unspecified route of administration on 24Feb2021 as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient had no known allergies. The consumer stated that after the first dose of vaccination the patient "gradually over 4-6 developed extremely swollen lymph nodes in the neck, throat, armpits, back which looks like a christmas tree pattern and the left side of his face from his chin to nose is numb and has not gone away". The patient asked as he was scheduled to receive second dose tomorrow, can the patient delay it for a week or so. The outcome of the event was unknown.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
PATIENT FAINTED, FEET AND HANDS CURLED INWARD, EYES ROLLED BACK.  SHE REGAINED CONSCIOUSNESS AFTER ABOUT 45-60 SECONDS..  PATIENT WAS SEATED AND DID NOT FALL.  PATIENT WAS VERY PALE AND SWEATY.
Out of nowhere, I began to have pain in my back and legs, which makes me unable to walk for most of the day. Everyday. I am usually an active person. I usually take frequent walks on a daily basis. Since I received my covid vaccine, I have been in so much pain that I have not been able to get out at all. Unless someone comes to pick me up, and even that is a challenge.
pt recvd vax 17AUG95 & 9SEP95 pt devel erythema multiforme;No further details were provided;
Information has been received from a RN concerning a 50 yr old white female with a pseudoephedrine hydrochloride (Sudafed), telithromycin (Ketek), and ampicillin allergy, asthma, hypertension, PCE, allergic rhinitis, fibrocystic disease and a TB converter, who on 05Nov04 at approx 13:30 was vaccinated into the left deltoid with a third dose of pneumococcal 23v polysaccharide vaccine (lot number 649111/0287P). There was no illness at the time of vaccination. On the evening of 05Nov05, the pt's left arm was red, swollen, uncomfortable, and started getting sore and was raised and progressively got worse. The pt was diagnosed with cellulitis. Unspecified medical attention was sought. Two weeks later, the pt recovered without serious complications. It was noted that there was no adverse events following prior vaccinations. No product quality complaint was involved. Additional information is not expected.
I had no immediate side effects after the first dose but 10 - 14 days later had about 24 hours of moderate to extreme dizziness.  Following the second shot (April 5) I also had no immediate side effects but later had extreme dizziness, mild headache and mild to moderate nausea about 2 weeks after the second dose.  I am still having these symptoms today.
About 2 hours after receiving the vaccine I had dizziness, chills, malaise, generalized body aches, and injection site pain. All of these reactions went away after about 24 hours, except the injection site pain lasted about 72 hours.
- Fever to 104 degrees F ~ 12 hours after vaccine; redness @ injection site.
After the patient received the vaccination, I drove her home and she ate supper. Within an hour of the injection, pt. began having severe chills, accompanied by violent shaking -- so bad that pt. could not hold a glass of water to take the Tylenol (two, 500-mg. tablets) I gave her, just in case she had a fever (though her forehead was not unusually warm to the touch). Patient also reported feeling nauseous. The patient went to bed, lying on a heated mattress pad, with a heating pad on her back, and covered with a sheet, a warm blanket, two comforters, and a terrycloth bathrobe atop the foregoing layers. The chills subsided after a while, but she had a second, equally severe bout later this evening (into the wee hours of the next morning, lasting until after 1:35 AM October 10).